AURKAIP1 and breast cancer: Since DDX5 has been elucidated to have a well-defined mechanism of action in tumors including breast cancer by reviewing the literature, we established DDX5 as a reciprocal target and further examined whether AURKAIP1 fostered TNBC development via the DDX5 mediator.